Social Determinants of Health, Resilience, and Premature Cognitive Aging in End-stage Renal Disease Funded Grant uri icon

description

  • Only 13% of the 780,000 adults living with end-stage renal disease (ESRD) have normal cognitive function. We found that 14.0% of ESRD patients aged 35-49 experience severe cognitive impairment and 2.9% have a co- occurring functional dependence suggestive of Alzheimer’s disease and related dementia (AD/ADRD). After dialysis initiation older (≥65) patients experience a 21-25% lifetime risk of AD/ADRD. Younger ESRD patients experience premature cognitive aging requiring the study of cognition and AD/ADRD across the lifespan. Black ESRD patients are more than twice as likely to develop cognitive impairment and 70%-78% more likely to be diagnosed with AD/ADRD; this disparity is comparable to a 10 year increase in age. While social determinants of health (SDOH) are known contributors to health disparities in community-dwelling older adults, its impact on cognitive aging among ESRD patients is understudied. ESRD patients are the ideal population to elucidate these mechanisms: 1) 30% of patients are Black; 2) 87% experience premature cognitive aging; 3) all enroll in a national registry and 65% in Medicare for measurement of institutional SDOH. For all adult ESRD patients in the national registry/Medicare database, we will glean 14 indicators of SDOH across all 5 domains [1) economic stability (median home value; median real estate tax; median gross rent; median monthly mortgage; % owner-occupied homes), 2) education (% attained bachelor’s degree; % attainted high school diploma), 3) health care (medically underserved areas; health professional shortage area), 4) neighborhood built environment (public transportation; % building vacancy; % greenspace), and 5) social/community (social fragmentation; social engagement)] from publicly available data using ZIP code at ESKD diagnosis and capturing changes over time) (Aim 1) and additionally using childhood Zip Codes (Aim 2). Then, we will link these data to our ongoing, NIA-funded, multi-center, prospective cohort study (FAIR, n=5,275) of aging and ESRD to fully characterize SDOH. This is the oldest (>12 years) ESRD cohort study that includes longitudinal measures global and domain specific cognitive function. Aim 1: To estimate the impact of SDOH on incident AD/ADRD. Aim 2: To quantify the contributions of lifecourse SDOH on cognitive impairment and decline. Aim 3: To test whether resilience protects against cognitive impairment and decline. ESRD patients are uniquely vulnerable to premature cognitive aging; SDOH are likely causes of health disparities in cognitive impairment, cognitive decline, and ADRD. By taking a lifecourse approach and engaging community, family, and patient stakeholders in all phases of our study, we will identify feasible targets for improving resilience in the face of SDOH. These potential targets for interventions and policies to counter SDOH will likely generalize to other populations with chronic diseases.

date/time interval

  • 2022 - 2027